Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine

Yoshihisa Higuchi*, Haruo Hattori, Toshiaki Kume, Masahiro Tsuji, Akinori Akaike, Kenshi Furusho

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

We measured the changes in nitric oxide (NO) metabolites in the brains of neonatal rats with hypoxic-ischemic damage. There were two peaks of NO metabolites in the lesioned side of the cortex without treatment: one during hypoxia and the other during the re-oxygenation period. Prehypoxic treatment with 7-nitroindazole, a selective neuronal NO synthase inhibitor, suppressed both peaks of NO metabolites, whereas prehypoxic treatment with aminoguanidine, a selective inducible NO synthase inhibitor, partially suppressed only the peak in the re-oxygenation period. These data suggest different roles of neuronal and inducible NO synthases in the pathogenesis of hypoxic-ischemic encephalopathy.

Original languageEnglish
Pages (from-to)47-49
Number of pages3
JournalEuropean Journal of Pharmacology
Volume342
Issue number1
DOIs
StatePublished - 1998/01/19

Keywords

  • (Rat, neonatal)
  • 7-Nitroindazole
  • Aminoguanidine
  • Hypoxic-ischemic encephalopathy
  • Nitric oxide (NO)

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine'. Together they form a unique fingerprint.

Cite this